218 related articles for article (PubMed ID: 16375890)
1. Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine.
Roberts JD; Gennings C; Shih M
Eur J Pharmacol; 2006 Jan; 530(1-2):54-8. PubMed ID: 16375890
[TBL] [Abstract][Full Text] [Related]
2. Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat.
Cox ML; Haller VL; Welch SP
Eur J Pharmacol; 2007 Jul; 567(1-2):125-30. PubMed ID: 17498686
[TBL] [Abstract][Full Text] [Related]
3. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine.
Cadoni C; Pisanu A; Solinas M; Acquas E; Di Chiara G
Psychopharmacology (Berl); 2001 Nov; 158(3):259-66. PubMed ID: 11713615
[TBL] [Abstract][Full Text] [Related]
4. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
Williams J; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration.
Cichewicz DL; McCarthy EA
J Pharmacol Exp Ther; 2003 Mar; 304(3):1010-5. PubMed ID: 12604676
[TBL] [Abstract][Full Text] [Related]
6. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
[TBL] [Abstract][Full Text] [Related]
7. Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by delta9-tetrahydrocannabinol.
Williams IJ; Edwards S; Rubo A; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2006 Jun; 539(1-2):57-63. PubMed ID: 16687136
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model.
Staahl C; Upton R; Foster DJ; Christrup LL; Kristensen K; Hansen SH; Arendt-Nielsen L; Drewes AM
J Clin Pharmacol; 2008 May; 48(5):619-31. PubMed ID: 18440921
[TBL] [Abstract][Full Text] [Related]
9. Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission.
Cadoni C; Valentini V; Di Chiara G
J Neurochem; 2008 Aug; 106(4):1586-93. PubMed ID: 18513369
[TBL] [Abstract][Full Text] [Related]
10. 1',1'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties.
Dajani EZ; Larsen KR; Taylor J; Dajani NE; Shahwan TG; Neeleman SD; Taylor MS; Dayton MT; Mir GN
J Pharmacol Exp Ther; 1999 Oct; 291(1):31-8. PubMed ID: 10490883
[TBL] [Abstract][Full Text] [Related]
11. The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions.
Naef M; Curatolo M; Petersen-Felix S; Arendt-Nielsen L; Zbinden A; Brenneisen R
Pain; 2003 Sep; 105(1-2):79-88. PubMed ID: 14499423
[TBL] [Abstract][Full Text] [Related]
12. [Effect of the synthetic cannabinoid dronabinol on central pain in patients with multiple sclerosis--secondary publication].
Svendsen KB; Jensen TS; Bach FW
Ugeskr Laeger; 2005 Jun; 167(25-31):2772-4. PubMed ID: 16014264
[TBL] [Abstract][Full Text] [Related]
13. The analgesic efficacy and safety of intra-articular morphine and mepivicaine following temporomandibular joint arthroplasty.
Zuniga JR; Ibanez C; Kozacko M
J Oral Maxillofac Surg; 2007 Aug; 65(8):1477-85. PubMed ID: 17656271
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department.
Borland M; Jacobs I; King B; O'Brien D
Ann Emerg Med; 2007 Mar; 49(3):335-40. PubMed ID: 17067720
[TBL] [Abstract][Full Text] [Related]
15. DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine.
Cheng HY; Laviolette SR; van der Kooy D; Penninger JM
Eur J Neurosci; 2004 Jun; 19(11):3033-41. PubMed ID: 15182311
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive activity of Delta9-tetrahydrocannabinol non-ionic microemulsions.
Lazzari P; Fadda P; Marchese G; Casu GL; Pani L
Int J Pharm; 2010 Jun; 393(1-2):238-43. PubMed ID: 20399844
[TBL] [Abstract][Full Text] [Related]
17. The early and delayed analgesic effects of ketamine after total hip arthroplasty: a prospective, randomized, controlled, double-blind study.
Remérand F; Le Tendre C; Baud A; Couvret C; Pourrat X; Favard L; Laffon M; Fusciardi J
Anesth Analg; 2009 Dec; 109(6):1963-71. PubMed ID: 19923527
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
Wallace M; Schulteis G; Atkinson JH; Wolfson T; Lazzaretto D; Bentley H; Gouaux B; Abramson I
Anesthesiology; 2007 Nov; 107(5):785-96. PubMed ID: 18073554
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model.
Staahl C; Christrup LL; Andersen SD; Arendt-Nielsen L; Drewes AM
Pain; 2006 Jul; 123(1-2):28-36. PubMed ID: 16600508
[TBL] [Abstract][Full Text] [Related]
20. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.
Kraft B; Frickey NA; Kaufmann RM; Reif M; Frey R; Gustorff B; Kress HG
Anesthesiology; 2008 Jul; 109(1):101-10. PubMed ID: 18580179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
